Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preemptive Lung Impedance-Guided Therapy in Evolving Acute Heart Failure in Acute Myocardial Infarction Patients

NCT01616121 is registered in ClinicalTrials.gov with Hillel Yaffe Medical Center as lead sponsor.

NCT NCT01616121
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01616121 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preemptive Lung Impedance-Guided Therapy in Evolving Acute Heart Failure in Acute Myocardial Infarction Patients
Lead sponsor
Hillel Yaffe Medical Center
Phase
Phase 3
Overall status
Completed
Start date
June 1, 2002
Completion date
July 1, 2014
Enrollment
654 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure